Evidence map›Paper›PMID 40813918›Full record

ReviewNature reviews. Neurology2025

Spreading depolarization as a therapeutic target in migraine.

Andrea M Harriott, Cenk Ayata

Abstract readReview
In one paragraph

Review in Nature reviews. Neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Hemiplegic migraine: genetics and pathophysiology.The Journal of clinical investigation · 2026
    Review
  3. Review
  4. Article
  5. Spreading depolarization: A wave that precedes and drives cerebral ischemic cell death-Target for neuroprotection.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Andrea M HarriottNeurovascular Research Unit, Massachusetts General Hospital, Boston, MA, USA. aharriott@mgb.org.ORCID 0000-0003-0417-7586
Cenk AyataNeurovascular Research Unit, Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-3644-6042

Funding

Sex Differences in the Role of Gonadal Hormones and the Hypothalamus in Migraine with Aura.K08NS124991 · NINDS · MASSACHUSETTS GENERAL HOSPITAL · PI Andrea M Harriott · 2022 to 2026
$1.1M
NINDS NIH HHS K08 NS124991
6 · The paper itself

Abstract

Migraine with aura is characterized by recurrent attacks of visual and, occasionally, sensory, language and/or motor disturbances, typically followed by headache. Migraine with aura can be associated with allodynia and vascular and psychiatric comorbidities. The electrophysiological cause of the aura is cortical spreading depolarization, a wave of depolarization that propagates slowly across the cortical surface, producing reversible metabolic and electrochemical perturbations. In this Review, we focus on the relationship of spreading depolarization with migraine aura and migraine headache. Abundant evidence causally links spreading depolarization to the headache phase of migraine with aura, as it can activate trigeminal nociceptors, produce dural and cortical inflammation, and induce trigeminal pain behaviour in rodents. In experimental models, migraine prophylaxis reduces susceptibility to spreading depolarization, and abortive treatments abrogate trigeminal pain behaviour that is induced by spreading depolarization. Although questions remain about the role of spreading depolarization in migraine with aura and models of spreading depolarization need to be refined, the cumulative evidence suggests that spreading depolarization is a putative target for therapeutic intervention in migraine. Elucidating the mechanisms by which spreading depolarization can induce trigeminal pain could facilitate drug discovery, and models of spreading depolarization could be effective screening platforms for migraine therapies.

Indexed as

Cortical Spreading DepressionMigraine DisordersMigraine with AuraAnimalsHumans

Identifiers

PMID40813918
PMCPMC13157258

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.